Skip to content

Prospective Randomized Controlled Trial of VR Cognitive Training in Reducing Postoperative Delirium in Elderly Patients With Cerebral Small Vessel Disease Undergoing Non-Cardiac Surgery

Prospective Randomized Controlled Trial of VR Cognitive Training in Reducing Postoperative Delirium in Elderly Patients With Cerebral Small Vessel Disease Undergoing Non-Cardiac Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103421
Enrollment
Unknown
Registered
2025-05-29
Start date
2025-05-31
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative delirium

Interventions

Preoperative Training Group:VR cognitive function training
Preoperative Non-Training Group:Virtual Scene

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age>=65; 2. Preoperative MRI-confirmed cerebral small vessel disease; 3. Scheduled to undergo non-cardiac, non-craniotomy procedures under general anesthesia; 4. Anticipated surgical duration >2 hours; 5. ASA physical status classification: I–III; 6. No use of cognitive-enhancing medications within 3 months prior to surgery; 7. Voluntary participation with signed informed consent;

Exclusion criteria

Exclusion criteria: 1. Contraindications to cranial MRI (e.g., cardiac pacemaker, metallic implants, etc.); 2. Intolerance to VR equipment during pre-training adaptation (e.g., dizziness, nausea, vomiting, or other subjective discomfort); 3. Severe visual or auditory impairment; 4. Severe hepatic or renal dysfunction; 5. Pre-existing neuropsychiatric disorders (e.g., schizophrenia, epilepsy, Parkinson’s disease, or active delirium); 6. Inability to complete preoperative neuropsychological assessments (e.g., dementia, deaf-mutism, or communication barriers); 7. History of cerebrovascular events within 3 months (e.g., stroke or transient ischemic attack); 8. Use of sedatives, antidepressants, or history of psychoactive substance abuse/alcoholism;

Design outcomes

Primary

MeasureTime frame
postoperative delirium;

Secondary

MeasureTime frame
cognitive function;Amplitude of Low-Frequency Fluctuation(ALFF) of brain region;Regional Homogeneity(ReHo) of brain region;Fractional Amplitude of Low-Frequency Fluctuation(fALFF) of brain region;

Countries

China

Contacts

Public ContactZhengqian Li

Peking University Third Hospital

zhengqianli@hsc.pku.edu.cn+86 10 82267260

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026